Double hit on melanoma unlocks barrier to immunotherapy

April 2018

Researchers at EPFL and UNIL have discovered a dangerous liaison between immune cells that limits the efficacy of immunotherapy in melanoma. But they also found a way to disrupt it. The study is published in Science Translational Medicine.


November 2018

Oktober 2018

September 2018

November 2017

September 2017

August 2017